CD274 and neoplasm: Some authors showed that high PD-L1 in tumor cells (TCs) was associated with better OS and longer treatment-free interval (TFI) after primary chemotherapy in recurrent cases, whereas high PD-L1 in tumor-infiltrating immune cells (TICs) was associated with worse OS as well as MSI (124).